Literature DB >> 22884870

Anti-diarrheal activity of (-)-epicatechin from Chiranthodendron pentadactylon Larreat: experimental and computational studies.

Claudia Velázquez1, José Correa-Basurto, Normand Garcia-Hernandez, Elizabeth Barbosa, Emiliano Tesoro-Cruz, Samuel Calzada, Fernando Calzada.   

Abstract

ETHNOPHARMACOLOGICAL RELEVANCE: Chiranthodendron pentadactylon Larreat is frequently used in Mexican traditional medicine as well as in Guatemalan for several medicinal purposes, including their use in the control of diarrhea. AIM OF THE STUDY: This work was undertaken to obtain additional information that support the traditional use of Chiranthodendron pentadactylon Larreat, on pharmacological basis using the major antisecretory isolated compound from computational, in vitro and in vivo experiments.
MATERIALS AND METHODS: (-)-Epicatechin was isolated from ethyl acetate fraction of the plant crude extract. In vivo toxin (Vibrio cholera or Escherichia coli)-induced intestinal secretion in rat jejunal loops models and sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) analysis on Vibrio cholera toxin were used in experimental studies while the molecular docking technique was used to conduct computational study.
RESULTS: The antisecretory activity of epicatechin was tested against Vibrio cholera and Escherichia coli toxins at oral dose 10 mg/kg in the rat model. It exhibited the most potent activity on Vibrio cholera toxin (56.9% of inhibition). In the case of Escherichia coli toxin its effect was moderate (24.1% of inhibition). SDS-PAGE analysis revealed that both (-)-epicatechin and Chiranthodendron pentadactylon extract interacted with the Vibrio cholera toxin at concentration from 80 μg/mL and 300 μg/mL, respectively. Computational molecular docking showed that epicatechin interacted with four amino acid residues (Asn 103, Phe 31, Phe 223 and The 78) in the catalytic site of Vibrio cholera toxin, revealing its potential binding mode at molecular level.
CONCLUSION: The results derived from computational, in vitro and in vivo experiments on Vibrio cholera and Escherichia coli toxins confirm the potential of epicatechin as a new antisecretory compound and give additional scientific support to anecdotal use of Chiranthodendron pentadactylon Larreat in Mexican traditional medicine to treat gastrointestinal disorders such as diarrhea.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22884870     DOI: 10.1016/j.jep.2012.07.039

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  6 in total

Review 1.  Pathogen-induced secretory diarrhea and its prevention.

Authors:  S Anand; S Mandal; P Patil; S K Tomar
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-07-29       Impact factor: 3.267

2.  Rapid cessation of acute diarrhea using a novel solution of bioactive polyphenols: a randomized trial in Nicaraguan children.

Authors:  Arthur Dover; Neema Patel; K T Park
Journal:  PeerJ       Date:  2015-05-21       Impact factor: 2.984

3.  Antiprotozoal, Antibacterial and Antidiarrheal Properties from the Flowers of Chiranthodendron pentadactylon and Isolated Flavonoids.

Authors:  Fernando Calzada; Teresa Juárez; Normand García-Hernández; Miguel Valdes; Oscar Ávila; Lilian Yepez Mulia; Claudia Velázquez
Journal:  Pharmacogn Mag       Date:  2017-04-18       Impact factor: 1.085

Review 4.  Review of the inhibition of biological activities of food-related selected toxins by natural compounds.

Authors:  Mendel Friedman; Reuven Rasooly
Journal:  Toxins (Basel)       Date:  2013-04-23       Impact factor: 4.546

Review 5.  Antibacterial and antidiarrheal activities of plant products against enterotoxinogenic Escherichia coli.

Authors:  J Daniel Dubreuil
Journal:  Toxins (Basel)       Date:  2013-11-07       Impact factor: 4.546

Review 6.  Therapeutic significance and pharmacological activities of antidiarrheal medicinal plants mention in Ayurveda: A review.

Authors:  Ashish Mishra; Ankit Seth; Santosh Kumar Maurya
Journal:  J Intercult Ethnopharmacol       Date:  2016-05-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.